• About
    • Team
    • Contact
  • Ophthalmics
  • Investors
    • AGM Notices
    • Financials
    • Research & Development
  • News


Genix Pharmaceuticals Corporation Receives Natural Product Number for Rechlor from Health Canada

Genix Proposes to Extend Warrants

Genix Receives Approval to Extend Warrants from the TSX Venture Exchange

Genix Announces Auditor Resignation

Genix Announces Change of Auditor

Genix Announces AGM Results

Genix Announces Warrant Repricing and Seeks Extension

Genix Announces TSX-V Approval of Warrant Amendments

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

NOTICE OF ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS

1 2 Next
Suite 300, 1055 West Hastings St, Vancouver, BC, V6E 2E9
604.609.6198
info@genixpharm.com

LINKS

  • Ophthalmics
  • Investors
  • News

OUR COMPANY

  • About
  • Investors
  • Contact
  • Disclaimers
  • Terms of service

OUR NEWSLETTER

Subscribe to the mailing list to receive updates on new arrivals, special offers and other information


© 2022 Created by Genix Pharmaceuticals